Peter A Elliott, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 6 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
25 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Elliott’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A134837 · Current
Licensed to practise in California · since 2015 · expires 2028-11-30 · George Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$42,952
Medicare paid this office $42,952 for 269 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 99 | $5,996 | $49 |
| Long return visit (40+ min) | 33 | $5,252 | $119 |
| Return visit (30+ min) | 45 | $3,538 | $74 |
| New patient visit (60+ min) | 16 | $2,418 | $151 |
| New patient visit (30+ min) | 37 | $2,403 | $65 |
See all 10 services
| Short return visit (20+ min) | 99 | $5,996 | $49 |
| Long return visit (40+ min) | 33 | $5,252 | $119 |
| Return visit (30+ min) | 45 | $3,538 | $74 |
| New patient visit (60+ min) | 16 | $2,418 | $151 |
| New patient visit (30+ min) | 37 | $2,403 | $65 |
| Diagnostic exam of bladder and urethra using an endoscope | 33 | $2,294 | $62 |
| Simple change of bladder tube | 30 | $1,798 | $42 |
| New patient visit (45+ min) | 20 | $1,459 | $73 |
| Biopsy of prostate gland | 13 | $1,345 | $103 |
| Ultrasound scan of pelvic region through rectum | 18 | $545 | $29 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Who their Medicare patients are
269 Original Medicare patients in 2024. Average age 72 · Under 65 10% · 85 and older 7% · Women 20% · Also on Medicaid 77% · Health risk score 1.68. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 74% · Diabetes 43% · Cancer 34% · Chronic kidney disease 26% · Coronary heart disease 25% · Heart failure 16% · Depression 16% · Atrial fibrillation 13% · COPD 10% · Dementia 9% · Stroke 6%.
The office billed $526,131, Medicare allowed $60,180 and paid $42,952; for 479 services of 47 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 269 | 479 | 72 | 1.68 | $526,131 | $42,952 |
| 2023 | 233 | 447 | 72 | 1.60 | $487,932 | $41,189 |
| 2022 | 213 | 424 | 72 | 1.43 | $336,269 | $31,881 |
| 2021 | 178 | 371 | 71 | 1.64 | $444,626 | $41,641 |
| 2020 | 142 | 236 | 75 | 1.63 | $163,968 | $19,704 |
| 2019 | 76 | 109 | 74 | 1.51 | $42,481 | $7,253 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 68 | $6,703 | $78 |
| Short return visit (20+ min) | 100 | $6,274 | $49 |
| Long return visit (40+ min) | 23 | $2,956 | $118 |
| Diagnostic exam of bladder and urethra using an endoscope | 34 | $2,574 | $68 |
| New patient visit (45+ min) | 19 | $1,871 | $98 |
| New patient visit (30+ min) | 11 | $682 | $62 |
| Simple change of bladder tube | 14 | $667 | $48 |
| Short return visit | 18 | $490 | $25 |
| Ultrasound scan of pelvic region through rectum | 12 | $360 | $28 |
2022: 8 services
| Short return visit (20+ min) | 106 | $6,691 | $51 |
| Return visit (30+ min) | 47 | $4,009 | $80 |
| Diagnostic exam of bladder and urethra using an endoscope | 32 | $2,257 | $61 |
| Biopsy of prostate gland | 19 | $2,232 | $117 |
| Long return visit (40+ min) | 16 | $2,138 | $134 |
| Short return visit | 45 | $1,490 | $30 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,194 | $52 |
| Ultrasound scan of pelvic region through rectum | 25 | $853 | $30 |
2021: 10 services
| Short return visit (20+ min) | 64 | $4,356 | $57 |
| Diagnostic exam of bladder and urethra using an endoscope | 45 | $3,792 | $64 |
| Long return visit (40+ min) | 21 | $3,135 | $136 |
| Return visit (30+ min) | 30 | $2,796 | $90 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $2,515 | $57 |
| Biopsy of prostate gland | 15 | $1,731 | $115 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,073 | $89 |
| Short return visit | 19 | $602 | $32 |
| Ultrasound scan of pelvic region through rectum | 17 | $494 | $29 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $234 | $20 |
2020: 6 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 18 | $3,553 | $197 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,566 | $87 |
| Short return visit (20+ min) | 35 | $1,429 | $37 |
| Return visit (30+ min) | 19 | $1,312 | $69 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $1,115 | $74 |
| Telephone medical discussion with physician, 5-10 minutes | 19 | $477 | $24 |
2019: 2 services
| Short return visit (20+ min) | 42 | $1,864 | $42 |
| Return visit (30+ min) | 13 | $870 | $67 |
Medicaid work
$12,150 in 2024
Medicaid paid $12,150 for 2,802 billed services this clinician did in 2024, up to 73 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 355 | $4,348 |
| Change of cystostomy tube; simple | 199 | $2,188 |
| New patient visit (30+ min) | 128 | $1,878 |
| Long return visit (40+ min) | 62 | $1,584 |
| Return visit (30+ min) | 92 | $1,507 |
| New patient visit (45+ min) | 13 | $427 |
| CYSTOURETHROSCOPY | 16 | $183 |
| Catheter, suprapubic/cystoscopic | 88 | $37 |
| Service | 24 | $0 |
| Service | 77 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 47 | $0 |
| Medication list documented in medical record (COA) | 487 | $0 |
| 2024 | 2,802 | 18 | 73 | $12,150 |
| 2023 | 1,042 | 14 | 34 | $5,446 |
| 2022 | 394 | 3 | 33 | $2,660 |
| 2021 | 242 | 3 | 26 | $2,582 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 338 | $1,644 |
| Return visit (30+ min) | 196 | $1,527 |
| CYSTOURETHROSCOPY | 42 | $700 |
| New patient visit (30+ min) | 42 | $681 |
| Long return visit (40+ min) | 13 | $369 |
| New patient visit (45+ min) | 28 | $356 |
| Change of cystostomy tube; simple | 15 | $107 |
| Service | 98 | $62 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 56 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 27 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 29 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 39 | $0 |
2022
| Short return visit (20+ min) | 277 | $1,528 |
| Return visit (30+ min) | 74 | $1,036 |
| Short return visit | 43 | $95 |
2021
| Short return visit (20+ min) | 189 | $1,364 |
| Return visit (30+ min) | 39 | $740 |
| Service | 14 | $477 |
Drugs they prescribed that Part D paid
$63,573
Pharmacies billed $63,573 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 315) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
235 generic and 80 brand-name prescriptions · $63,573 in drug cost · 25 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 48 | $41,150 | $857 |
| Gemtesa | 14 | $14,442 | $1,032 |
| Tolterodine Tartrate Er | 27 | $1,073 | $40 |
| Finasteride | 75 | $803 | $11 |
| Tamsulosin | 64 | $629 | $10 |
See all 7 drugs
| Myrbetriq | 48 | $41,150 | $857 |
| Gemtesa | 14 | $14,442 | $1,032 |
| Tolterodine Tartrate Er | 27 | $1,073 | $40 |
| Finasteride | 75 | $803 | $11 |
| Tamsulosin | 64 | $629 | $10 |
| Nitrofurantoin Mono-Macro | 11 | $452 | $41 |
| Oxybutynin Chloride Er | 24 | $228 | $9 |
Year by year
| 2024 | 315 | 96 | 0% (0) | 25% | $63,573 |
| 2023 | 228 | 81 | None | 21% | $52,819 |
| 2022 | 194 | 65 | 0% (0) | 16% | $32,881 |
| 2021 | 163 | 62 | None | 7% | $6,757 |
| 2020 | 68 | 37 | None | None | $2,211 |
| 2019 | 131 | 72 | 15% (19) | 11% | $8,495 |
| 2018 | 173 | 92 | 37% (64) | None | $4,598 |
| 2017 | 197 | 106 | 36% (71) | None | $3,826 |
| 2016 | 214 | 100 | 24% (51) | None | $9,314 |
| 2015 | 226 | 138 | 35% (79) | 7% | $11,011 |
| 2014 | 56 | 34 | 0% (0) | 23% | $2,363 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Myrbetriq | 39 | $38,218 | $980 |
| Finasteride | 65 | $2,507 | $39 |
| Tolterodine Tartrate Er | 14 | $2,127 | $152 |
| Oxybutynin Chloride Er | 25 | $1,193 | $48 |
| Tamsulosin | 42 | $1,130 | $27 |
2022: 4 drugs
| Myrbetriq | 21 | $21,267 | $1,013 |
| Finasteride | 67 | $1,277 | $19 |
| Tamsulosin | 57 | $739 | $13 |
| Oxybutynin Chloride Er | 17 | $680 | $40 |
2021: 3 drugs
| Finasteride | 45 | $740 | $16 |
| Tamsulosin | 50 | $611 | $12 |
| Oxybutynin Chloride Er | 13 | $556 | $43 |
2020: 2 drugs
| Tamsulosin | 12 | $288 | $24 |
| Finasteride | 12 | $93 | $8 |
2019: 3 drugs
| Tamsulosin | 26 | $724 | $28 |
| Finasteride | 24 | $563 | $23 |
| Tramadol | 15 | $101 | $7 |
2018: 6 drugs
| Finasteride | 30 | $695 | $23 |
| Tamsulosin | 20 | $674 | $34 |
| Tramadol | 33 | $237 | $7 |
| Hydrocodone-Acetaminophen | 26 | $195 | $7 |
| Terazosin | 16 | $183 | $11 |
| Ciprofloxacin | 17 | $120 | $7 |
2017: 6 drugs
| Tamsulosin | 26 | $1,109 | $43 |
| Finasteride | 33 | $812 | $25 |
| Hydrocodone-Acetaminophen | 34 | $303 | $9 |
| Tramadol | 35 | $262 | $7 |
| Ciprofloxacin | 27 | $191 | $7 |
| Terazosin | 12 | $138 | $11 |
2016: 6 drugs
| Tamsulosin | 34 | $2,132 | $63 |
| Finasteride | 37 | $1,384 | $37 |
| Ciprofloxacin | 34 | $285 | $8 |
| Tramadol | 33 | $259 | $8 |
| Hydrocodone-Acetaminophen | 16 | $221 | $14 |
| Terazosin | 16 | $193 | $12 |
2015: 4 drugs
| Tamsulosin | 22 | $1,235 | $56 |
| Ciprofloxacin | 54 | $501 | $9 |
| Tramadol | 53 | $415 | $8 |
| Hydrocodone-Acetaminophen | 18 | $330 | $18 |
2014: 1 drug
| Ciprofloxacin | 16 | $131 | $8 |
Money from drug and device companies
$236 in 2025
| 2025 | 2 | 2 | None | $236 |
| 2024 | 2 | 2 | None | $58 |
| 2020 | 1 | 1 | None | $115 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Lynparza | $121 | 1 payment
|
| Astellas Pharma US | Padcev | $115 | 1 payment
|
See all 2 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-04 | Lynparza | $121 |
| Astellas Pharma US | Meals · 2025-11-05 | Padcev | $115 |
See earlier years (2024, 2020)
2024: $58
| Bluewind Medical | Revi | $29 | 1 payment
|
| Coloplast | Luja Coude | $29 | 1 payment
|
2020: $115
| TissueTech | Prokera | $115 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1063857597
- Licence
- CA A134837California A134837: Current · expires 2028-11-30
- Trained
- George Washington University School of Medicine, 2013
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Student in a training program (390200000X)
- Mailing address
- 751 S Bascom Ave Fl 4, San Jose, CA, 95128
- NPI first listed
- 2013-05-10
- NPI last updated
- 2020-10-27
- NPI record certified
- 2020-10-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4733 W Sunset Blvd, Los Angeles, CA, 90027 · 2121 Santa Monica Blvd, Santa Monica, CA, 90404